Ident. | Authors (with country if any) | Title |
---|
000B01 (2009) |
C. Marin [Espagne] ; E. Aguilar [Espagne] ; G. Mengod [Espagne] ; R. Cortés [Espagne] ; J. A. Obeso [Espagne] | Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats |
000B25 (2009) |
Tultul Nayyar [États-Unis] ; Michael Bubser [États-Unis] ; Marcus C. Ferguson [États-Unis] ; M. Diana Neely [États-Unis] ; J. Shawn Goodwin [États-Unis] ; Thomas J. Montine [États-Unis] ; Ariel Y. Deutch [États-Unis] ; Twum A. Ansah [États-Unis] | Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation |
000B44 (2009) |
Franz Marxreiter [Allemagne] ; Silke Nuber [Allemagne] ; Mahesh Kandasamy [Allemagne] ; Jochen Klucken [Allemagne] ; Robert Aigner [Allemagne] ; Ralf Burgmayer [Allemagne] ; Sebastien Couillard-Despres [Allemagne] ; Olaf Riess [Allemagne] ; Jürgen Winkler [États-Unis, Allemagne] ; Beate Winner [Allemagne] | Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha‐synuclein |
000C57 (2008) |
Ronald L. Klein [États-Unis] ; Robert D. Dayton ; Jason B. Tatom ; Cynthia G. Diaczynsky ; Michael F. Salvatore | Tau expression levels from various adeno‐associated virus vector serotypes produce graded neurodegenerative disease states |
000E30 (2008) |
Darcy Litteljohn [Canada] ; Emily N. Mangano [Canada] ; Shawn Hayley [Canada] | Cyclooxygenase‐2 deficiency modifies the neurochemical effects, motor impairment and co‐morbid anxiety provoked by paraquat administration in mice |
000E58 (2008) |
Meir Plotnik [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Bilateral coordination of walking and freezing of gait in Parkinson’s disease |
000F27 (2007) |
Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie] | Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model |
000F50 (2007) |
M. J. Hurley [Royaume-Uni] ; P. H. Patel [Royaume-Uni] ; M. J. Jackson [Royaume-Uni] ; L. A. Smith [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] | Striatal leucine‐rich repeat kinase 2 mRNA is increased in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned common marmosets (Callithrix jacchus) with l‐3, 4‐dihydroxyphenylalanine methyl ester‐induced dyskinesia |
000F63 (2007) |
Jeffrey M. Hausdorff [Israël, États-Unis] ; Justine Lowenthal [Israël] ; Talia Herman [Israël] ; Leor Gruendlinger [Israël] ; Chava Peretz [Israël] ; Nir Giladi [Israël] | Rhythmic auditory stimulation modulates gait variability in Parkinson's disease |
001004 (2007) |
Hyun Jung Park [Corée du Sud] ; Phil Hyu Lee [Corée du Sud] ; Young Whan Ahn [Corée du Sud] ; Yun Jung Choi [Corée du Sud] ; Gwang Lee [Corée du Sud] ; Da-Yong Lee [Corée du Sud] ; Eun S. Chung [Corée du Sud] ; Byung Kwan Jin [Corée du Sud] | Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action |
001040 (2007) |
Emilie Lacombe ; Carole Carcenac ; Sabrina Boulet ; Claude Feuerstein [France] ; Anne Bertrand ; Annie Poupard ; Marc Savasta [France] | High‐frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l‐3,4‐dihydroxyphenylalanine in dopaminergic denervated rats |
001071 (2007) |
Soon S. Park [États-Unis] ; Emily M. Schulz [États-Unis] ; Daewoo Lee [États-Unis] | Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by α‐synuclein |
001234 (2006) |
Ana I. Rojo [Espagne] ; Celia Montero [Espagne] ; María Salazar [Espagne] ; Ryan M. Close [États-Unis] ; Javier Fernández-Ruiz [Espagne] ; Miguel A. Sánchez-González [Espagne] ; María Rosa De Sagarra [Espagne] ; Vernice Jackson-Lewis [États-Unis] ; Carmen Cavada [Espagne] ; Antonio Cuadrado [Espagne] | Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice |
001254 (2006) |
David W. Anderson [États-Unis] ; Kristin A. Bradbury [États-Unis] ; Jay S. Schneider [États-Unis] | Neuroprotection in Parkinson models varies with toxin administration protocol |
001264 (2006) |
Rossitza Baltadjieva [Israël] ; Nir Giladi [Israël] ; Leor Gruendlinger [Israël] ; Chava Peretz [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease |
001362 (2006) |
Rebecca E. Colebrooke [Royaume-Uni] ; Trevor Humby [Royaume-Uni] ; Patrick J. Lynch [Royaume-Uni] ; Daniel P. Mcgowan [Royaume-Uni] ; Jing Xia [Royaume-Uni] ; Piers C. Emson [Royaume-Uni] | Age‐related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease |
001392 (2005) |
Mahmoud M. Iravani [Royaume-Uni] ; Sergio Costa [Royaume-Uni] ; Ghassan Al-Bargouthy [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Bai-Yun Zeng [Royaume-Uni] ; Mikko Kuoppam Ki [Royaume-Uni] ; Jose A. Obeso [Espagne] ; Peter Jenner [Royaume-Uni] | Unilateral pallidotomy in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets exhibiting levodopa‐induced dyskinesia |
001403 (2005) |
Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann [Canada] ; Lori K. Smith [Canada] ; Karim Fouad [Canada] | The unilateral 6‐OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis |
001406 (2005) |
Mahmoud M. Iravani [Royaume-Uni] ; Clement C. M. Leung [Royaume-Uni] ; Mona Sadeghian [Royaume-Uni] ; Claire O. Haddon [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation |
001416 (2005) |
Pedro Barroso-Chinea [Espagne] ; Ignacio Cruz-Muros [Espagne] ; María S. Aymerich [Espagne] ; Manuel Rodríguez-Díaz [Espagne] ; Domingo Afonso-Oramas [Espagne] ; José L. Lanciego [Espagne] ; Tomás González-Hernández [Espagne] | Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells |
001417 (2005) |
Colum D. Mackinnon [États-Unis] ; Ruth M. Webb [Royaume-Uni] ; Paul Silberstein [Royaume-Uni] ; Steven Tisch [Royaume-Uni] ; Peter Asselman [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson's disease |